Skip to main content
. Author manuscript; available in PMC: 2021 Jun 1.
Published in final edited form as: Pediatr Blood Cancer. 2020 May 9;67(7):e28370. doi: 10.1002/pbc.28370

TABLE 2.

Number of patients with grade 3–4 toxicities attributable to study therapy

Cycle1 (n = 11 patients) Subsequent cycles (n = 9 patients)
Grade 3 Grade 4 Grade 3 Grade 4
Neutropenia 2 5 3 1
Thrombocytopenia 3 2 3 3
Lymphopenia 2 2
Anemia 5 5
Fever 3
Febrile neutropenia 1 1
Cellulitis 1
Dehydration 1
Dyspnea 1
Fatigue 1
Myalgia 1
ALT elevation 1 1
Motor neuropathy 1